News >

CMS Reins in Spending Under 340B, Garnering Praise, Criticism

Tony Hagen @oncobiz
Published: Thursday, Nov 02, 2017

A newly announced CMS policy to redistribute savings under the 340B Drug Discount Program so that Medicare beneficiaries save money on copayments has garnered a mixture of praise and criticism from supporters and critics of the program.

Established in 1992, the 340B program required drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at reduced prices.


CMS Finalizes Policies that Lower Out-of-Pocket Drug Costs and Increase Access to High-Quality Care [news release]. Baltimore, MD: CMS Newsroom; November 2, 2017.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication